Potassium arsenite shows promise for CFSChronic fatigue syndrome (CFS) associated with Staphylococcus spp. bacteremia, responsive to potassium arsenite 0.5% in a veterinary surgeon and his coworking wife, handling with CFS animal cases.
Strong potential but limited evidence
We investigated the impact of potassium arsenite on chronic fatigue syndrome (CFS) in two veterinary professionals. After struggling with CFS despite various treatments, they turned to a low dosage of potassium arsenite for ten days. Remarkably, both experienced a complete remission of their symptoms, and follow-up tests showed a notable improvement, including the disappearance of the bacteria from their blood.
While this suggests a potential link between bacterial infections and CFS, it's important to note that broader implications for treatment require more extensive research. This case prompts intriguing questions about the role of infections and alternative therapies in managing CFS.
Read More
We examined a unique case of an 18-month-old boy diagnosed with Gitelman syndrome, a rare condition leading to developmental delays.
His symptoms included psychomotor retardation and low potassium levels. Genetic tests confirmed mutations in the SLC12A3 gene, responsible for this condition.
After oral potassium supplementation, we observed remarkable improvement in his potassium levels and developmental progress. This case highlights the importance of recognizing Gitelman syndrome in young children with growth and developmental issues, as early treatment can lead to positive outcomes.
Read More
We investigated the relationship between magnesium levels in red blood cells and chronic fatigue syndrome (CFS). A case-control study revealed that CFS patients had lower magnesium levels than healthy individuals.
In a randomized, double-blind trial, 32 CFS patients received either magnesium sulphate or a placebo for six weeks. Those treated with magnesium reported significant improvements in energy, emotional wellbeing, and pain relief, with twelve out of fifteen feeling better.
In contrast, only three out of seventeen patients on placebo reported any improvement. Overall, these findings suggest that magnesium treatment may positively impact the wellbeing of those suffering from CFS.
Read More
Magnesium shows limited benefit for fatigueMagnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium.
Moderate relevance due to mixed results
We investigated how magnesium levels relate to chronic fatigue by studying 93 patients with unexplained fatigue.
Around 47% of participants showed magnesium deficiency, linked to reduced plasma antioxidant capacity.
Although magnesium supplementation didn't increase blood glutathione levels, we observed improved magnesium stores and vitamin E levels.
However, this did not equate to a significant boost in antioxidant activity or a decrease in lipid vulnerability. Therefore, while magnesium may help improve some parameters, it is not a panacea for chronic fatigue syndrome.
Read More
We aimed to understand the effects of magnesium sulfate treatment on a patient with chronic fatigue syndrome. The case involved a 29-year-old woman experiencing severe fatigue alongside various symptoms, including swelling lymph nodes and muscle pain.
After other treatments failed to provide relief, we administered magnesium sulfate intravenously once a week. Remarkably, after six weeks, the patient reported a significant reduction in fatigue and improved daily functioning, eventually leading to her discharge from the hospital.
Read More